Information from Industry - Sponsored CME Supplement

Challenges in Treating Patients with Tardive Dyskinesia

Publish date: November 1, 2021
This activity is supported by an independent educational grant from Neurocrine Biosciences.
By
Greg Mattingly
MD & Manish Jha
MBBS

 


 

In this supplement to Current Psychiatry, Greg Mattingly, MD and Manish K. Jha, MBBS review dilemmas and treatment options for patients with tardive dyskinesia.


Click here to read the supplement and earn free CME/CE credits.


 

Recommended Reading

Boxed warnings: Legal risks that many physicians never see coming
MDedge Psychiatry
Clinicians underprescribe behavior therapy for preschool ADHD
MDedge Psychiatry
Antidepressant may cut COVID-19–related hospitalization, mortality: TOGETHER
MDedge Psychiatry
Iatrogenic hyponatremia in a patient with bipolar disorder
MDedge Psychiatry
I have a dream … for psychiatry
MDedge Psychiatry
Service animals and emotional support animals: Should you write that letter?
MDedge Psychiatry
80% of Americans research recommendations post-visit
MDedge Psychiatry
Borderline personality disorder: 6 studies of biological interventions
MDedge Psychiatry
Medical transition in transgender patients
MDedge Psychiatry
Open notes: Big benefits, few harms in psychiatry, experts say
MDedge Psychiatry